Why is Boston Bio falling/rising?

As of 09-Sep, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 8.08, which represents a decrease of 0.42 or 4.94%. The stock has underperformed its sector by 4.21% today and has been on a consecutive downward trend for the last two days, with a total decline of 5.94% during this period. Additionally, the stock's performance over the past week shows a drop of 4.60%, while it has slightly decreased by 0.25% over the past month. The stock is currently trading above its 50-day and 100-day moving averages but below its 5-day, 20-day, and 200-day moving averages. Notably, there has been a significant drop in investor participation, with delivery volume falling by 18.57% compared to the 5-day average.
In the broader market context, the Sensex has shown a positive return of 1.18% over the past week and 1.56% over the past month, indicating that the market is generally performing well while Boston Bio is struggling. This contrast highlights the stock's underperformance relative to the benchmark. The lack of available positive or negative factors further complicates the understanding of the stock's recent movement, as there are no specific catalysts or issues identified that could explain the decline. Overall, the combination of falling investor interest and poor relative performance against the benchmark suggests a challenging environment for Boston Bio Systems Ltd.